Skip to content
Substance use & MAT

You are pregnant. You use substances. You are still welcome here.

The Materna Health Solutions perinatal substance use program is built on what works: evidence-based medication, harm reduction, and continuity of care. No surprise reports. No shaming. No conditional warmth.

If you are in immediate danger, call 911. If you are using opioids and worried about overdose, naloxone is free and over-the-counter at most pharmacies. We can ship it to you within 48 hours, no appointment needed.

A group of women supporting one another

17%

Of pregnant people who screen positive

For substance use of any kind, AUDIT-C and standard screening combined

< 30%

Of those who get evidence-based MAT

Even when their OB knows they need it. The barrier is access, not refusal.

~50%

Reduction in NAS severity

When buprenorphine is started before delivery instead of after

0

Pregnant patients we lose to follow-up

When SUD support is built into the prenatal app, not bolted on

Our approach

What we believe about pregnancy and substance use.

Materna's clinical leadership comes from ASAM, ACOG, and addiction-medicine practice. The four principles below shape every screening, every visit, every chart note.

No CPS calls without cause.

A positive screen is not a report. We follow ACOG and ASAM guidance: substance use disorder is a treatable condition, not child abuse. Reports happen only when state-mandated, with the patient informed.

Harm reduction, plain language.

If you are not ready to stop, we still want you in care. Naloxone training, fentanyl test strips, hepatitis screening, safer-use information, and judgment-free conversation about what is realistic for you right now.

MAT integrated, not gated.

Buprenorphine and methadone are first-line for opioid use disorder in pregnancy. Materna providers can prescribe and co-manage with addiction medicine. Same-day starts available.

Postpartum is the highest-risk window.

Overdose deaths peak 7 to 12 months postpartum. We do not stop the screening, the support, or the MAT after delivery. Coverage continues for the full 12 months.

What treatment looks like

MAT, plain language.

Buprenorphine (Subutex)

First-line for opioid use disorder in pregnancy. Daily dose, taken at home. Reduces cravings and protects against overdose. NAS in baby is treatable and short-term. Most patients start within 24 hours of intake. Does not require an inpatient stay.

Methadone

Daily dose at a federally licensed clinic. Strong evidence in pregnancy. Some patients prefer the structure. NAS may be longer than with buprenorphine but manageable. Materna helps with same-day clinic intake and transportation.

Counseling and peer support

Bilingual perinatal counselors trained in motivational interviewing. Peer recovery specialists who have been through pregnancy and recovery themselves. Telehealth available so you do not have to leave the house.

Harm reduction supplies

Free naloxone (Narcan) kits shipped to your address. Free fentanyl test strips. Information on safer use, hepatitis screening, and HIV PrEP. We will not let the perfect be the enemy of the alive.

If you are using right now

A short, honest checklist.

  • Have naloxone within reach. It is free, OTC, and we will mail it.
  • Never use alone. Call the Never Use Alone hotline (1-800-484-3731) if you must.
  • Do not mix opioids with benzodiazepines or alcohol if you can avoid it.
  • Test what you have. Fentanyl is in almost everything sold as something else.
  • If you want to stop, we can start MAT today, no inpatient stay required.
  • If you do not want to stop, we still want you in prenatal care. Both can be true.

24/7 lines

  • SAMHSA National Helpline

    1-800-662-4357

    24/7. Free. Confidential. EN + ES.

  • Pregnancy & Recovery line

    1-855-662-7724

    Specifically for pregnant and postpartum people.

  • Postpartum Support International

    1-800-944-4773

    For mood and substance concerns. Press 1 for Spanish.

  • Crisis Text Line

    Text HOME to 741741

    24/7 text-based crisis support.

For providers

Your role in changing the trajectory.

Two-thirds of pregnant patients with OUD never reach a buprenorphine-prescribing provider. The evidence is overwhelming, the access is not. Materna's perinatal SUD workflow includes universal screening (AUDIT-C, validated SUD short-form), warm handoff to MAT, harm-reduction supplies, and 12 months of postpartum continuity. CME on perinatal addiction is built into provider onboarding.

You don't have to figure this out alone.

Sign in or call. Same person every time. We do not transfer your call seven times.